Industry Veteran Becomes the First Contact Lens Company Executive to Serve
SAN RAMON, Calif., February 3, 2022—The Vision Council has elected CooperVision President Jerry Warner to a three-year term on its Board of Directors. The global organization promotes comprehensive growth in the vision care industry through education, advocacy, research, consumer outreach, strategic relationship building, and industry forums.
“The Vision Council is pleased to welcome Jerry as a director at large,” said Ashley Mills, CEO of The Vision Council. “As the first contact lens company representative to have a seat on our Board, Jerry offers valuable perspective and experience following years of active membership and volunteering from the CooperVision team. We are confident that with the support our strong and passionate Board members, we can have a productive and fulfilling year. There is much to look forward to in 2022 and we are excited to lead the industry forward together.”
Prior to his promotion to President of CooperVision, which took effect this month, Warner was the company’s Executive Vice President and President, Americas and Global Commercial Functions. He has also held roles as President of the Americas region and Senior Vice President of Global Marketing for the contact lens leader.
Warner said, “It is an honor to serve in this capacity, advocating for and helping create partnerships across the industry from which everyone benefits—manufacturers, practitioners, retailers, and consumers. The Vision Council is tireless in its efforts to enable better vision for better lives, which mirrors CooperVision’s own purpose to help improve the way people see each day.”
In addition to his new role, Warner is also on the Board of Trustees for the Optometric Center of New York, the affiliated foundation of the SUNY College of Optometry.
About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Media Contact
Heather Kowalczyk, APR, McDougall Communications
heather@mcdougallpr.com or +1-585-330-4878